-Dr. Abdullah Al-Eisa completed his dermatology training at the University of British Columbia, Canada, and obtained both the Canadian and American Boards of Dermatology in 1990. He contributed to the establishment of the first Dermatology Diploma in Riyadh in 1992 and later played a key role in developing the Saudi Board of Dermatology Training Program in 1994. He served at King Faisal Specialist Hospital for 19 years and founded the Kingdom’s first group dermatology and cosmetic practice, Derma Clinics, in 1996. Dr. Al-Eisa also completed a fellowship in anti-aging and regenerative medicine and has held prominent leadership roles, including Secretary General of the Pan-Arab Dermatology League. He has organized major national dermatology conferences, including Saudi Derm.

-Professor Faisal Alzahrani is a molecular biologist at King Abdulaziz University in Jeddah, Saudi Arabia. He serves as a professor in the Department of Biochemistry and is the principal investigator at the Stem Cell Unit within the King Fahd Medical Research Centre. With an extensive publication record of over forty peer-reviewed studies, Professor Alzahrani is also the editor-in-chief of the College of Science Journal. He has held various administrative and advisory roles at the university, including Vice Dean for Student Affairs and Advisor to the Vice President for Graduate Studies and Scientific Research. In addition, Professor Alzahrani is an experienced consultant in biotechnology, genomics, and medical research. He is actively involved in social work, serving on the Board of Directors of the Generations Care Association, the Board of Trustees of Al-Rajhi University, and as Vice Chairman of the Future Leaders Association. In 2024, he was selected by the British Council for the Cultural and Creativity Award, recognising inspiring figures who have made a significant impact among UK alumni.

-Dr. Islam M. Saadeldin, DVM, MVS, Ph.D., is a Senior Scientist at King Faisal Specialist Hospital & Research Centre in Saudi Arabia, Adjunct Professor at Alfaisal University, and Professor of Physiology at Zagazig University, Egypt He earned his Ph.D. in Reproductive and Developmental Biology from Seoul National University and has built an internationally recognized career in reproductive biology, extracellular vesicles, embryo technology, and regenerative medicine. His research focuses on infertility, embryo–maternal communication, organoid modeling, and extracellular vesicle–mediated cellular interactions, bridging fundamental science with translational and clinical applications. Dr. Saadeldin has authored more than 160 peer-reviewed SCI/SCIE publications, holds multiple patents registered with the Korean Intellectual Property Office, and has edited books published by Springer-Nature and Bentham Science He has received numerous prestigious awards, including the Fuller W. Bazer SSR International Scientist Award and the IETS Early Career Achievement Award, and has been listed among the world’s top 2% scientists according to Stanford University and Scopus citations. In addition to his research leadership, he actively mentors graduate students and serves on editorial boards and international scientific societies, contributing to global advancements in reproductive and regenerative sciences.

-Dr. Namsha Al-Hajri is a consultant obstetrician and gynecologist specializing in mature women’s health and menopause care. She graduated from King Saud University and completed her residency training at King Fahad Hospital, National Guard Health Affairs, Riyadh. She later pursued a clinical fellowship in Mature Women’s Health and Menopause at the University of Toronto. Dr. Al-Hajri is an Assistant Professor at King Abdullah bin Abdulaziz University Hospital, where she founded the Mature Women’s Health and Menopause Unit and established the residency training program. She currently practices in Riyadh and is an active national and international speaker, as well as an examiner for the Saudi Commission for Health Specialties.

-Dr. Dzihan Abazovic is an Emergency Medicine Specialist with a strong commitment to regenerative medicine and blood management—fields he began exploring during his residency training. Recognizing early the transformative potential of regenerative therapies, Dr. Abazovic became one of the pioneers in his region to apply stem cell–based and blood-derived treatments in clinical practice. Following his tenure as Head of Emergency Medicine in Ulcinj, he transitioned in 2013 to focus exclusively on regenerative medicine, joining Renova Clinic as Medical Director and subsequently collaborating with additional clinics to further expand his clinical and translational expertise. Over the course of his career, Dr. Abazovic has authored more than 40 scientific publications, achieving an h-index of 9 with over 550 citations. His dedication to innovation has extended into the development and implementation of longevity programs, reinforcing his leadership in healthspan-oriented therapeutic strategies. Through strategic collaborations with leading institutions—including Sidra Medicine Hospital, the Technology Innovation Institute (TII), and the Abu Dhabi Stem Cell Institute—Dr. Abazovic continues to contribute to advancements at the forefront of regenerative and longevity medicine.

-Dr. Fatimah Alanazi holds a PhD in Biosciences with a concentration in Cell and Molecular Biology from George Mason University, USA She also earned her M.Sc. and B.Sc. degrees in Biochemistry from King Saud University. Her academic and research training spans molecular biology, immunology, cancer biology, and regenerative medicine, with strong expertise in advanced laboratory techniques including cell culture, flow cytometry, molecular assays, and protein analysis. Dr. Alanazi has extensive research experience at King Faisal Specialist Hospital & Research Centre and has contributed to multiple high-impact publications in immunology, extracellular vesicles, and transplantation biology Her work focuses on cellular and molecular mechanisms underlying immune regulation and disease progression, reflecting her commitment to translational biomedical research and scientific advancement.

-Dr. Asma Abdulrazak Alanazi is an Assistant Professor of Physiology at the College of Medicine, King Saud bin Abdulaziz University for Health Sciences, and a clinical specialist in Flow Cytometry within the Division of Immunology at King Abdulaziz Medical City . She earned her PhD in Physiology from the University of Birmingham, United Kingdom, with research focused on mesenchymal stem cell recruitment and migration. Her academic background also includes a Master’s degree in Physiology from Ball State University, USA, and a bachelor’s degree in clinical laboratory science from King Saud University. Dr. Alanazi’s research centers on stem cell biology, immunology, and multiple sclerosis, with particular interest in stem cell signaling, migration, differentiation, and therapeutic applications in regenerative medicine . She has authored more than 25 scientific publications and contributed to several books, while actively leading and collaborating on funded research projects investigating inflammatory mediators, microRNAs, and novel peptide therapies. In addition to her research contributions, she plays a significant academic role in teaching, supervising student research, and serving on scientific and institutional committees.

-Meshal Alsharafa is a Research Laboratory Technologist currently working at the Health Sciences Research Center at Princess Nourah bint Abdulrahman University . He holds a Bachelor of Science in Clinical Laboratory Sciences from King Saud University and is currently pursuing a Master of Science in Clinical Laboratory Sciences (Clinical Biochemistry). His professional training includes experience at King Faisal Specialist Hospital and Research Centre and National Guard Health Affairs, where he developed strong expertise in laboratory operations, regulatory compliance, and advanced diagnostic techniques. Meshal has played a key role in assisting with the establishment of the HSRC Tissue Banking and Histopathology Unit and serves as Supervisor of the Advanced Imaging Unit . His technical competencies include histopathology, cytopathology, electron microscopy procedures, immunohistochemistry staining, and laboratory safety in anatomic pathology. In addition to his laboratory leadership, he contributes to accreditation and quality initiatives as a Medical Laboratory Assessor with the Saudi Accreditation Center and serves as Treasurer of the ISO Technical Committee 212 under the Saudi Scientific Society for Preventive Health

-Zaha Al-Makhlafi is a Senior Research Technology Specialist in the Flow Cytometry Unit at the Research Center of Princess Nourah bint Abdulrahman University, Riyadh . She holds a Bachelor’s degree in Clinical Laboratory Sciences from King Saud University and is certified in Cytometry by the American Society of Clinical Pathology (ASCP). With over two decades of experience in leading tertiary institutions—including King Fahad Medical City and King Faisal Specialist Hospital & Research Centre—she has developed extensive expertise in both clinical and research flow cytometry applications. Al-Makhlafi specializes in advanced multicolor immunophenotyping, leukemia and lymphoma diagnostics, PNH testing, cell cycle analysis, apoptosis assays, transplant cross-matching, lymphocyte subset enumeration, and cell sorting . She has played a key role in establishing the Flow Cytometry Research Unit at Princess Nourah University, organizing specialized workshops, contributing to CAP accreditation processes, and leading quality and standardization initiatives within the laboratory. Her contributions also extend to collaborative research projects and peer-reviewed publications in clinical immunology and transplantation sciences, reflecting her long-standing commitment to advancing cytometry practice and laboratory excellence.

-Dr. Tarek Khamis is a Lecturer of Pharmacology at the Faculty of Veterinary Medicine, Zagazig University, Egypt, with a PhD in Molecular Pharmacology specializing in stem cells, gene therapy, and regenerative medicine . He also serves in multiple leadership roles, including Administrative and Technical Director of the Stem Cells, Regenerative Medicine, and Molecular Biology Unit, and Technical Manager of the Central Laboratory at Zagazig University. His academic and research trajectory focuses on molecular follow-up of stem cell–based therapies, particularly in diabetes and its systemic complications. Dr. Khamis has authored more than 130 international peer-reviewed publications (primarily Q1 and Q2 journals) with a Scopus h-index of 18. His research spans mesenchymal stem cells, exosomes, nanomedicine, molecular signaling pathways, autophagy, oxidative stress, and gene expression analysis across metabolic, hepatic, renal, and reproductive disease models. He has led and participated in funded national and international research projects and actively contributes to scientific training through workshops and international conferences in stem cell biology, molecular pharmacology, and translational regenerative medicine.

-An accomplished anatomic and clinical pathologist, he is a Fellow of the Royal College of Pathologists (UK) and a Fellow of the Ackerman Academy of Dermatopathology. He served as Chairman of Operative Pathology at King Abdulaziz Medical City from 2009 to 2025 and currently acts as a Senior Advisor for Digital Pathology at the Ministry of Health. In recognition of his outstanding contributions, he was awarded the Lifetime Achievement Award in Pathology in Saudi Arabia in 2025. He is internationally recognized as the first inventor of digital pathology. His expertise extends to stem cell and regenerative medicine technologies, where he continues to contribute to innovation, strategic development, and the advancement of modern diagnostic and regenerative practices.